Uncategorized

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is reducing everyday burdens.

While prominent physicians can provide companies with valuable guidance during development, their perspective is limited when it comes to projecting how well or how readily a new product will be adopted. Here’s how to perform rigorous commercial diligence.

After receiving the FDA’s greenlight for Hunter syndrome drug Avlayah, Denali Therapeutics CEO Ryan Watts saw the culmination of 20 years of hard work unraveling the mysteries of the blood-brain barrier.

Premium hikes, plan redesigns and other efforts from the Minnesota-based company to wrangle medical spending bore fruit in the first quarter. UnitedHealth’s stock jumped accordingly.

Las células dendríticas, centinelas del sistema inmunitario, desempeñan un papel fundamental en la inmunidad: detectan amenazas y activan las células T para combatir infecciones y tumores. Comprender cómo se regulan estas células es fundamental tanto para po …

Hayley Park will oversee BSCA’s prescription drug programs. The insurer has worked to overhaul its pharmacy management model in a bid to lower drug costs.

Unos científicos han demostrado que es posible cultivar tomates y producir energía solar de forma simultánea, una estrategia clave para afrontar el peligro de la escasez de agua.   El equipo que ha realizado el trabajo lo integran investigadores de la Universidad de Sevil …

Medtronic formed a commercial agreement with Pulnovo alongside its investment.

New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault wrote.